Work

Phase I study of the duocarmycin semisynthetic derivative KW-2189 given daily for five days every six weeks.

Year: 1998

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: S R Alberts, C Erlichman, J M Reid, J A Sloan, M M Ames, R L Richardson, R M Goldberg

Institution: Mayo Clinic

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1954088862

FWCI: 0.341

Cites:

Cited by: 25

Related to: 10